Acurx Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary

Acurx Pharmaceuticals

14/11/2022 14:32

* Acurx Pharmaceuticals Inc  ACXP.OQ  reported a quarterly
adjusted loss of 32 cents​​ per share for the quarter ended in
September. The mean expectation of two analysts for the quarter
was for a loss of 28 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Acurx Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 32 cents​.
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Acurx Pharmaceuticals Inc shares had fallen by 3.0% this
quarter and lost 32.7% so far this year.
    * The company reported a quarterly loss of $3.54 million.
    * Wall Street's median 12-month price target for Acurx
Pharmaceuticals Inc is $13.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
14 at 02:32 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.28          -0.32          Missed
 Mar. 31 2022      -0.33          -0.26          Beat
 Dec. 31 2021      -0.40          -0.22          Beat